Skin and fat necrosis of the breast following methylene blue dye injection for sentinel node biopsy in a patient with breast cancer

Singh-Ranger G, Mokbel K: The sentinel node biopsy is a new standard of care for patients with early breast cancer. Int J Fertil Womens Med. 2004, 49 (5): 225-7.

Mokbel K, Mostafa A: The role of subareolar blue dye in identifying the sentinel node in patients with invasive breast cancer. Curr Med Res Opin. 2001, 17 (2): 93-5. 10.1185/030079901317010720.

Giuliano AE, Kirgan DM, Guenther JM, Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994, 220: 391-401.

Cimmino VM, Brown AC, Szocik JF, Pass HA, Moline S, De SK, Domino EF: Allergic reactions to isosulfan blue during sentinel node biopsy – a common event. Surgery. 2001, 130 (3): 439-42. 10.1067/msy.2001.116407.

Simmons RM, Smith SM, Osborne MP: Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization. Breast J. 2001, 7 (3): 181-3. 10.1046/j.1524-4741.2001.007003181.x.

Thevarajah S, Huston TL, Simmons RM: A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer. Am J Surg. 2005, 189 (2): 236-9. 10.1016/j.amjsurg.2004.06.042.

Tuttle TM: Technical advances in sentinel lymph node biopsy for breast cancer. Am Surg. 2004, 70 (5): 407-13.

Eldrageely K, Vargas MP, Khalkhali I, Venegas R, Burla M, Gonzalez KD, Vargas HI: Sentinel lymph node mapping of breast cancer: a case-control study of methylene blue tracer compared to isosulfan blue. Am Surg. 2004, 70 (10): 872-5.

Stradling B, Aranha G, Gabram S: Adverse skin lesions after methylene blue injections for sentinel lymph node localization. Am J Surg. 2002, 184 (4): 350-2. 10.1016/S0002-9610(02)00945-5.

Raimer SS, Quevedo EM, Johnston RV: Dye rashes. Cutis. 1999, 63: 103-106.

Borgstein PJ, Meijer S, Pijpers R: Intradermal blue dye to identify the sentinel lymph node in breast cancer. Lancet. 1997, 349: 1668-1669. 10.1016/S0140-6736(05)62634-7.

Singh-Ranger G, Mokbel K: Capsular contraction following immediate reconstructive surgery for breast cancer – An association with methylene blue dye. Int Semin Surg Oncol. 2004, 11, 1 (1): 3-10.1186/1477-7800-1-3.

Lane KL, Vallera R, Washington K, Gottfried MR: Endoscopic tattoo agents in the colon. Tissue responses and clinical implications. Am J Surg Pathol. 1996, 20 (10): 1266-70. 10.1097/00000478-199610000-00013.

Govaert GA, Oostenbroek RJ, Plaisier PW: Prolonged skin staining after intradermal use of patent blue in sentinel lymph node biopsy for breast cancer. Eur J Surg Oncol. 2005, 31 (4): 373-5. 10.1016/j.ejso.2004.12.009.

Woltsche-Kahr I, Komericki P, Kranke B, Brabek E, Horn M, Schuller-Petrovic S, Richtig E, Aberer W: Anaphylactic shock following peritumoral injection of patent blue in sentinel lymph node biopsy procedure. 2. Eur J Surg Oncol. 2000, 26 (3): 313-4. 10.1053/ejso.1999.0888.

Mostafa A, Carpenter R: Anaphylaxis to patent blue dye during sentinel lymph node biopsy for breast cance. Eur J Surg Oncol. 2001, 27 (6): 610-10.1053/ejso.2001.1174.

Aubard Y, Mollard J, Ducloux T, Monteil J, Fermeaux V, Desfougeres M, Gana J, Serdouma E: Detection of the sentinel lymph node under local anaesthesia in early-stage breast cancer: feasibility study in a series of 78 unselected patients. Eur J Gynaecol Oncol. 2004, 25 (2): 178-82.

Dubost JL, Chevallier H: Allergic reactions to patent blue violet: mechanisms, frequency and treatment. Phlebologie. 35 (3): 739-46. 1982 Jul-Sep